The 99 references in paper S. Alferov V., S. Karpov A., K. Grinev M., A. Vasilyev N., С. Алфёров В., С. Карпов А., К. Гринёв М., А. Васильев Н. (2013) “ПОСТОЯННЫЙ СОСУДИСТЫЙ ДОСТУП ДЛЯ ГЕМОДИАЛИЗА: СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ // PERMANENT VASCULAR ACCESS FOR HEMODIALYSIS: A MODERN VIEW” / spz:neicon:nefr:y:2013:i:6:p:56-70

1
Ермоленко ВМ. Хронический гемодиализ. Медицина, М., 1982; 278с
(check this in PDF content)
2
Kolff WJ, Berk HTh. The artificial kidney: a dialyzer with a great area. ActaMedScand1944; 117:121-134
(check this in PDF content)
3
Quinton WE, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960; 104-113
(check this in PDF content)
4
Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275 (20): 1089–1092
(check this in PDF content)
5
Dunlop MG, Mackinlay JY, Jenkins AM. Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986; 68:203-206
(check this in PDF content)
6
Stonebridge PA, Edington D, Jenkins AM. ‘Brachial/basilic vein’ transposition forvascular access. J R Coll Surg Edinb 1995; 40:219-220
(check this in PDF content)
7
Bryan FA. Seventh Annual Progress ReportOct. 1, 1974 – Oct. 1, 1975 Report No AK-7-7-1387. Research Triangle Institute, Triangle Park, NC. The National Dialysis Registry – Artificial Kidneys – Chronic Uremia Program, National Institutes of Health, Bethesda, MD, 1975
(check this in PDF content)
8
Geis WP, Giacchino J. A game plan for vascular access for hemodialysis. Surgical Rounds 1980; 132(3):332-335
(check this in PDF content)
9
Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicaemia in dialysis patients:incidence, risk factors and prognosis. Kidney Int 1999; 55: 1081-1090
(check this in PDF content)
10
Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int 1999; 56: 1-17
(check this in PDF content)
11
U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997; 30(Suppl.1):S160S177
(check this in PDF content)
12
Feldman HI, Kobrin S, Wasserstein A. Hemodialysis Vascular Access Morbidity. J Am Soc Nephrol 1996; 7:523-535
(check this in PDF content)
13
Chazan JA, London MR, Pono L. The impact of diagnosisrelated groups on the cost ofhospitalisation for end-stage renal disease patients at Rhode Island Hospital from 1987 to1990. Am J Kidney Dis 1992; 6:523-525
(check this in PDF content)
14
Смирнов АВ. Заместительная почечная терапия. Нефрология 2011; 15(1): 33-46
(check this in PDF content)
15
Енькина ТН, Лукичев БГ, Енькин АА, Гринев КМ. Влияние шунтового кровотока по артериовенозной фистуле на развитие сердечной недостаточности у больных с хронической почечной недостаточностью, корригированной программным гемодиализом. Нефрология 2000; 4(1):48-52
(check this in PDF content)
16
Rutherford RB. Rutherford’s vascular surgery / Cronenwett Jack L., Johnston K. Wayne; associate editors, Cambria Richard et al.7th ed. Philadelphia: Saunders Elsevier, 2010: 1169-1173
(check this in PDF content)
17
Wilson SE. Vascular Access. Principles and Practice / Samuel Eric Wilson. – 5th edition. Philadelphia: Lippincott Williams & Wilkins, a Wolter Kluwer business, 2010:173-174
(check this in PDF content)
18
NKF-DOQI clinical practice guidelines for vascular access. New York, National Kidney Foundation, 1997; 191p
(check this in PDF content)
19
Konner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 2000 Sep; 15(9): 1317-1325
(check this in PDF content)
20
Konner K, Nonnast-Daniel B, Ritz E. The Arteriovenous Fistula. Journal of the American Society of Nefrology 2003; 14: 1669-1680
(check this in PDF content)
21
Wixon CL, Hughes JD, Mills JL. Understending strategies for the treatment of ischemic steal syndrome after hemodialysis access. J Am Coll Surg 2000 Sept; 191(3): 301-310
(check this in PDF content)
22
Dhingra RK, Young EW, Hulbert-Shearon TE et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001 Oct; 60(4): 1443-1451
(check this in PDF content)
23
Kojecky Z, Utikal P, Sekanina Z et al., Venous hypertension following average arterio-venous fistula for haemodialysis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002 Dec; 146(2):77-79
(check this in PDF content)
24
Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997 Aug 15; 127(4): 275-280
(check this in PDF content)
25
Verghese S, Padmaja P, Sudha P et al. Central venous catheter related infections. J Commun Dis 1999 Mar; 31(1): 1-4
(check this in PDF content)
26
Rodriguez JA, Armadans L, Ferrer E et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15(3):402-408
(check this in PDF content)
27
Chin AI, Chang W, Fitzgerald JT et al. Intra-access blood flow in patients with newly created upper-arm arteriovenous native fistulae for hemodialysis access. Am J Kidney Dis 2004;44(5):850858
(check this in PDF content)
28
Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17(Suppl 1):S1-27
(check this in PDF content)
29
K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis adequacy Peritoneal Dialysis Adequacy Vascular Access. Am J Kidney Dis 2006; 48(Suppl 1):S1-158
(check this in PDF content)
30
Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 2005; 41(2):279-284
(check this in PDF content)
31
Hurt AV, Batello-Cruz M, Skipper BJ et al. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146(6):844-847
(check this in PDF content)
32
Liu Z, Zhu B, Wang X et al. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. Kidney Int 2007; 72(10):1249-1254
(check this in PDF content)
33
Canaud B. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients. Kidney Int 2007; 72(10):1179-1181
(check this in PDF content)
34
Hurlbert SN, Mattos MA, Henretta JP et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998; 6:652-656
(check this in PDF content)
35
Lenz BJ, Veldenz HC, Dennis JW et al. A three-year followup on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 1998; 28(3):464-470
(check this in PDF content)
36
Schuman ES, Standage BA, Ragsdale JW, Gross GF. Reinforced versus non reinforced polytetrafluoroethylene grafts for hemodialysis access. Am J Surg 1997; 173:407
(check this in PDF content)
37
Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol 2003; 14(11):2942-2947
(check this in PDF content)
38
Ram SJ, Sachdeva BA, Caldito GC et al. Thigh grafts contribute significantly to patients’ time on dialysis. Clin J Am Soc Nephrol 2010; 5(7):1229-1234
(check this in PDF content)
39
Hessinger M, Zitta S, Holzer H, Tiesenhausen K. [Dialock® – an alternative to Permcath trade mark and Access Graft] [Article in German]. Zentralbl Chir 2003; 128 (9): 753–756
(check this in PDF content)
40
Metry G, Uhlin F, Almroth G. Swedish experience of the Dialock. Scand J Urol Nephrol 2007; 41 (3): 249–253
(check this in PDF content)
41
Moran JE, Prosl F. Totally implantable subcutaneous devices for hemodialysis access. Contrib Nephrol 2004; 142: 178–192
(check this in PDF content)
42
Rayan SS, Terramani TT, Weiss VJ, Chaikof EL. The LifeSite Hemodialysis Access System in patients with limited access. J Vasc Surg 2003; 38 (4): 714–718
(check this in PDF content)
43
Ross JR. Successful treatment of a LifeSite Hemodialysis Access System pocket infection with large-volume kanamycin solution irrigation. Adv Ren Replace Ther 2003; 10 (3): 248–253
(check this in PDF content)
44
Szczepanska M, Szprynger K, Stoksik P et al. [Port device central venous access in children with chronic renal disease – personal experience][Article in Polish]. Wiad Lek 2006; 59 (11–12): 814–818
(check this in PDF content)
45
Richard T. Hemodialysis access without a shunt or catheter: the circulating port. J Vasc Access 2007; 8 (2): 86–90
(check this in PDF content)
46
McAllister TN, Maruszewski M, Garrido SA et al. Effectiveness of haemodialysis access with an autologous tissueengineered vascular graft: a multicentre cohort study. Lancet 2009; 373:1440-1446
(check this in PDF content)
47
Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299(18):2164-2171
(check this in PDF content)
48
Kaufman JL, Garb JL, Berman JA et al. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg 1997; 185(1):74-79
(check this in PDF content)
49
Polo JR, Tejedor A, Polo J et al. Long-term follow-up of 6-8 mm brachioaxillary polytetrafluorethylene grafts for hemodialysis. Artif Organs 1995; 19(11):1181-1184
(check this in PDF content)
50
Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997; 48(2):114-117
(check this in PDF content)
51
Miller PE, Tolwani A, Luscy CP et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56(1):275-280
(check this in PDF content)
52
Lockhart ME, Robbin ML, McNamara MM, Allon M. Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients. Nephrol Dial Transplant 2004; 19(10):2564-2569
(check this in PDF content)
53
Lok CE, Allon M, Moist L et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17(11):3204-3212
(check this in PDF content)
54
Huijbregts HJ, Bots ML, Wittens CH et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3:714-719
(check this in PDF content)
55
Silva MB Jr, Hobson RW 2nd, Pappas PJ et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27(2):302-307
(check this in PDF content)
56
Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63:346-352
(check this in PDF content)
57
Obialo CI, Tagoe AT, Martin PC, Asche-Crowe PE. Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients. ASAIO J 2003; 49:435-439
(check this in PDF content)
58
Segal JH, Kayler LK, Henke P et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis 2003; 42(1):151-157
(check this in PDF content)
59
Ravani P, Brunori G, Mandolfo S et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15(1):204-209
(check this in PDF content)
60
Linden J, Lameris TW, van den Meiracker AH et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47(6):1013-1019
(check this in PDF content)
61
Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol 2007; 18(6):1936-1941
(check this in PDF content)
62
Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33(5):910-916
(check this in PDF content)
63
Konner K, Hulbert-Shearon TE, Roys EC, Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62(1):329-338
(check this in PDF content)
64
Faiyaz R, Abreo K, Zaman F et al. Salvage of poorly developed arteriovenous fistulae with percutaneous ligation of accessory veins. Am J Kidney Dis 2002; 39:824-827
(check this in PDF content)
65
Falk A, Teodorescu V, Lou WY et al. Treatment of “swing point stenoses” in hemodialysis arteriovenous fistulae. Clin Nephrol 2003; 60(1):35-41
(check this in PDF content)
66
Beathard GA, Arnold P, Jackson J et al. Aggressive treatment of early fistula failure. Kidney Int 2003; 64(4):1487-1494
(check this in PDF content)
67
Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the “failing to mature” arteriovenous fistula. Clin J Am Soc Nephrol 2006; 1(2):275-280
(check this in PDF content)
68
Sottiurai VS, Stephens A, Champagne L et al. Comparative results of early and delayed cannulation of arteriovenous graft in haemodialysis. Eur J Vasc Endovasc Surg 1997; 13:139-141
(check this in PDF content)
69
Rayner HC, Pisoni RL, Gillespie BWet al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63(1):323-330
(check this in PDF content)
70
Brunori G, Ravani P, Mandolfo S et al. Fistula maturation: doesn’t time matter at all? Nephrol Dial Transplant 2005; 20(4):684-687
(check this in PDF content)
71
Saran R, Dykstra DM, Pisoni RL et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004; 19(9):2334-2340
(check this in PDF content)
72
Saran R, Pisoni RL, Young EW. Timing of first cannulation of arteriovenous fistula: are we waiting too long? Nephrol Dial Transplant 2005; 20(4):688-690
(check this in PDF content)
73
Bonalumi U, Civalleri D, Rovida S et al. Nine years’ experience with end-to-end arteriovenous fistula at the ‘anatomical snuffbox’ for maintenance haemodialysis. Br J Surg 1982; 69:486-488
(check this in PDF content)
74
Munda R, First MR, Alexander JW et al. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249(2):219-222
(check this in PDF content)
75
Young EW, Dykstra DM, Goodkin DA et al. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61(6):2266-2271
(check this in PDF content)
76
Bender MH, Bruyninckx CM, Gerlag PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg 1994; 20:808-813
(check this in PDF content)
77
Hodges TC, Fillinger MF, Zwolak RM, et al. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 1997; 26(6):1009-1019
(check this in PDF content)
78
Coburn MC, Carney WI Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20(6):896-902
(check this in PDF content)
79
Iwashima Y, Horio T, Takami Y et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002; 40:974-982
(check this in PDF content)
80
Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol 1998; 18(5):379-383
(check this in PDF content)
81
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37:S137-181
(check this in PDF content)
82
Tesio F, De Baz H, Panarello G et al. Double catheterization of the internal jugular vein for hemodialysis: indications, techniques, and clinical results. Artif Organs 1994; 18(4):301-304
(check this in PDF content)
83
Saad TF. Bacteriemia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34(6):1114-1124
(check this in PDF content)
84
Suhocki PV, Conlon PJ Jr, Knelson MH et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28:379-386
(check this in PDF content)
85
Atherikul K, Schwab SJ, Conlon PJ. Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant 1998; 13:745-749
(check this in PDF content)
86
Dunn J, Nylander W, Richie R. Central venous dialysis access: experience with a dual-lumen, silicone rubber catheter. Surgery 1987; 102(5):784-789
(check this in PDF content)
87
Oliver MJ, Mendelssohn DC, Quinn RR et al. Catheter potency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol 2007; 2(6):1201-1206
(check this in PDF content)
88
Oliver MJ, Rothwell DM, Fung K et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15(7):1936-1942
(check this in PDF content)
89
Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62(2):620-626
(check this in PDF content)
90
Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003; 42(5):1013-1019
(check this in PDF content)
91
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15(2):477-486
(check this in PDF content)
92
Thomson PC, Stirling CM, Geddes CC, et al. Vascular access in haemodialysis patients: a modifiable risk factor for bacteremia and death. QJM 2007; 100(7):415-422
(check this in PDF content)
93
Pisoni RL, Arrington CJ, Albert JM et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53:475-491
(check this in PDF content)
94
Astor BC, Eustace JA, Powe NR et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16(5):1449-1455
(check this in PDF content)
95
Allon M, Daugirdas J, Depner TA et al. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006; 47(3):469-477
(check this in PDF content)
96
Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62(4):1109-1124
(check this in PDF content)
97
Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16(3):189-196
(check this in PDF content)
98
Yigla M, Nakhoul F, Sabag A et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123: 1577-1582
(check this in PDF content)
99
Nakhoul F, Yigla M, Gilman R et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arteriovenous access. Nephrol Dial Transplant 2005; 20: 1686-1692 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)